报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 3.21% | -48.89% | 14.64% | 82/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 2.8% | -41.79% | 78.34% | 66/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 1.57% | -9.77% | -78.7% | 73/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 7.37% | 38.79% | 17.36% | 43/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 6.28% | 77.9% | 30.56% | 53/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 4.81% | 113.78% | 176.44% | 45/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 1.74% | 39.2% | -67.23% | 66/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 5.31% | -60.67% | 50.42% | 74/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 3.53% | -69.91% | 56.89% | 78/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 2.25% | -72.99% | 80% | 82/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 1.25% | 2% | -90.74% | 83/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 13.5% | -52.76% | 15.09% | 28/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 11.73% | 2% | 40.82% | 26/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 8.33% | -53.28% | -70.85% | 23/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2020-12-31 | 28.58% | 0.49% | 60.29% | 6/160 | 3.74% | 汇宇制药 | 28.14% | 行业排名> |
2020-06-30 | 17.83% | 2% | -37.31% | 4/160 | 4.24% | 哈三联 | 27.17% | 行业排名> |
2019-12-31 | 28.44% | 57.48% | 57.48% | 6/160 | 2.78% | 汇宇制药 | 55.94% | 行业排名> |
2018-12-31 | 18.06% | 500% | 500% | 23/160 | 7.09% | 河化股份 | 45.32% | 行业排名> |
2017-12-31 | 3.01% | 2% | 2% | 102/160 | 9.66% | 汇宇制药 | 31.9% | 行业排名> |